$PBIO Investor Ideas Potcasts, Cannabis News and Stocks on the Move

Delta, Kelowna, BC – February 28, 2020 www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:

https://www.investorideas.com/Audio/Podcasts/2020/022820-StocksToWatch.mp3

SHARE PODCAST:

Hear Investor ideas cannabis potcast on iTunes

Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com “Potcast” featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

In today’s podcast we look at a few public announcements.

Pressure BioSciences, Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, and other industries, announced the official opening of its new Ultra Shear Technology (“UST”) Demonstration Laboratory. The UST Demo Lab is located in the Company’s South Easton, Massachusetts facility.

A major purpose of the UST Demo Lab is to showcase the ability of the Company’s revolutionary UST Platform to process CBD oil into true, high quality, water-soluble nanoemulsions. It is expected that nanoemulsions of CBD will be more stable, have superior aesthetic quality, and offer higher bioavailability than the standard macro/microemulsions used in most CBD products today (Nanoemulsions, in Handbook of Nanomaterials in Industrial Applications, Ghodake and Patravale, 2018). A second purpose is to invite potential purchasers of the Company’s UST-based BaroShear Systems (initial release expected Q4 2020) to evaluate how their CBD and other product formulations work with the Company’s revolutionary UST platform.

This Company today released a new short video demonstrating how CBD oil from an independent manufacturer was processed into a clear, water-soluble nanoemulsion using a UST-based, first generation BaroShear system. The video shows the CBD oil and water mixture prior to and after UST processing.

Link to new short video showcasing the UST Demonstration Lab: PBI UST CBD Video

Kenneth F. Micciche, Director of PBI’s UST Program, said: “We processed samples of CBD oil formulations from several highly interested companies over the past two months, in an effort to optimize the service we announced today. The results speak for themselves: one group (Vegas CBD Factory) ordered six BaroShear K45 systems (for Q4 2020 delivery and installation). We believe several more companies who participated in the early evaluation process are close to giving us their purchase orders. The ability to showcase the UST platform in real life, and see the final product first-hand, has been shown to be vital to our marketing efforts. As has been said in the past: ‘build it and they will come’. The opening of the UST Demo Lab is a critical accomplishment in our UST sales and marketing strategy.”

Richard T. Schumacher, President and CEO of PBI commented: “The initial reactions from manufacturers of topical and ingestible cannabidiol products processed in our lab during the trial period have been extremely positive. They quickly saw how they could realize substantial cost reductions while eliminating the overloading of poorly water-soluble CBD and other cannabinoids into products to achieve targeted dosing levels. We believe our breakthrough technology platform provides them with a new-found ability to provide safe and effective dosing for their customers, which in turn should stimulate greater growth in the market for CBD-based products overall, and strong sales of our BaroShear product line when it is released to the market later this year.”

CannTrust Holdings Inc. (TSX: TRST) (NYSE: CTST) announced that on February 27, 2020 the Company received written notification from the New York Stock Exchange that CannTrust is no longer in compliance with the NYSE’s continued listing standard rules because the per share trading price of the Company’s common shares has fallen below the NYSE’s share price rule. The NYSE requires the average closing price of a listed company’s common shares to be at least US $1.00 per share over a consecutive 30 trading-day period. As of February 25, 2020, the 30 trading-day average closing price of the Company’s common shares was US $0.99.

In accordance with the NYSE’s rules, CannTrust has six months from the receipt of the notice to regain compliance. During this time period, the Company’s common shares will continue to be listed and trade on the NYSE as usual.

Under NYSE rules, CannTrust can regain compliance at any time during the six-month period if its common shares have a closing price of at least US $1.00 on the last trading day of any calendar month during the period and also have an average closing price of at least US $1.00 over the 30 trading-day period ending on the last trading day of that month or on the last day of the cure period.

Indiva Limited (TSXV:NDVA) (OTCQX:NDVAF) and Lift & Co. Corp. (TSXV:LIFT) (OTCQB:LFCOF) announced the release of Indiva’s CannSell branded education module. The CannSell certification program, created by Lift & Co., in exclusive partnership with MADD Canada, is currently utilized in eight Canadian jurisdictions. CannSell also serves as the provincially-mandated training program for all cannabis retail workers in Ontario. These frontline staff members are responsible for educating consumers on the safe use of cannabis where it is sold. The Indiva education experience on the CannSell platform offers an overview of the Company, its product portfolio, and its commitment to quality, innovation and sustainability.

“We are proud to partner with Lift & Co. in educating this important community about Indiva and our products,” Niel Marotta, Indiva’s President and Chief Executive Officer, said. “Many consumers do not know what to purchase prior to entering a store. Budtenders are a great first point of contact for those interested in learning more about cannabis. Their guidance makes cannabis more accessible and helps Canadians make informed decisions. We look forward to staying connected to the budtender community and working in partnership with organizations like Lift & Co. to educate the public about cannabis, cannabis products and responsible use.”

“Through the CannSell platform, Lift & Co. is able to support brands like Indiva to deliver brand education directly to Canadian budtenders who are critical to consumers’ cannabis education and eventual purchase decisions,” Matei Olaru, CEO of Lift & Co., said. “Whether it’s through this platform, lift.co or Cohesion, Lift & Co.’s entire platform connects brands like Indiva to consumers through several key touchpoints.”

James E. Wagner Cultivation Corporation (TSXV: JWCA.V) (OTCQX: JWCAF) announced that it has entered into a Memorandum of Understanding with CannNext BV, a company based in Amsterdam, the Netherlands, pursuant to which JWC will assist CannNext with its tender to the Government of the Netherlands for a licence to produce medical cannabis in the Netherlands.

In support of CannNext’s Tender, JWC has provided certain necessary commitments and attestations required by the Government of the Netherlands. In addition, in connection with the Tender process and, if the Tender is successful, the resulting anticipated production of medical cannabis in the Netherlands, JWC will provide CannNext with industry knowledge and experience related to the cultivation and production of medical cannabis for a consumer market.

The MOU outlines the parties’ intention to collaborate in developing cannabis cultivation best-practices. This will involve research and development related to strains, grow methods and lighting practices. JWC and CannNext also intend to negotiate a definitive agreement pursuant to which CannNext will agree to represent JWC in the Netherlands and the European Union for licensing of JWC’s GrowthSTORM technology. JWC will also acquire a minority equity position in CannNext.

CannNext is focused on the research and development related to improving yields for controlled medical cannabis cultivation both for and with its own clients. CannNext’s state-of-the-art government licensed, research facility is also located in the Netherlands, and can be immediately converted to production.

“We believe that shaping alliances with companies that focus on high-end medical cannabis will benefit both parties to realize a global reach and leverage combined knowledge”, says Eric Uleman, managing director of CannNext. “Combining the long-standing cultivation knowledge of JWC and our focus on light and grow strategies, will result in increasing our chances of becoming a winner in the Dutch tender. We visited the JWC site at 530 Manitou Drive, Kitchener, Ontario, and found that it aligns with our view of how a best-in-class indoor facility would look. JWC delivers the best medical product for patients driven by personal passion and its advanced cultivation technology.”

“Our proprietary GrowthSTORM technology is the foundation for our success here in Canada,” says Nathan Woodworth, CEO and President of JWC. We believe by sharing our technology and knowledge with CannNext, we will establish an important gateway to the European Union Market. The Netherlands has reputation for being a frontrunner in medical cannabis and represents one of the largest recreational markets in the world.”

Investor ideas reminds all listeners to read our disclaimers and disclosures on the Investorideas.com website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp

Or www.potcasts.ca

To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.

Investorideas.com podcasts are also available on iTunes, Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com – News that Inspires Big Investing Ideas

Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns: Crypto Corner, Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change, Exploring Mining the AI Eye.

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.

Learn more about sponsoring this podcast or be a guest and our other branded content opportunities at Investorideas.com

Follow us on Cannabis Social Media

https://www.facebook.com/Investorideaspotcasts/

https://twitter.com/MJInvestorIdeas

https://www.instagram.com/investorideas_potcast/